Bill Werner
Sr. Director, Analytical Assay Development at Audentes Therapeutics - San Francisco, California, US
Bill Werner's Colleagues at Audentes Therapeutics
Bill Werner's Contact Details
(415) 818-1005
Belmont, California, United States
Audentes Therapeutics
Bill Werner's Company Details
Audentes Therapeutics is a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases. We are leveraging our AAV gene therapy technology platform and proprietary manufacturing expertise to develop programs across three modalities: gene replacement, vectorized exon skipping, and vectorized RNA knockdown. Our product candidates are showing promising therapeutic profiles in clinical and preclinical studies across a range of neuromuscular diseases. Audentes is a focused, experienced and passionate team driven by the goal of improving the lives of patients. If you are interested in learning more about our company, please do not hesitate to contact us.